CYTOSORBENTS CORP (CTSO)
US23283X2062 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -27.53M | -28.51M | -32.81M | -24.56M | -7.84M | |||
| Depreciation Amortization | 1.60M | 1.46M | 880.00K | 730.00K | 660.00K | |||
| Change In Working Capital | -2.36M | 2.36M | -3.56M | 640.00K | -760.00K | |||
| Interest Paid | 506.09K | 376.67K | 0.00 | 0.00 | 1.13M | |||
| Other non cash items | 4.92M | 3.03M | 7.26M | 9.18M | 2.32M | |||
| OPERATING CASH FLOW | -23.37M | -21.66M | -28.23M | -14.01M | -5.61M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -383.26K | -936.24K | -6.46M | -4.28M | -1.68M | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -383.26K | -936.24K | -6.46M | -4.28M | -1.68M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 5.00M | 0.00 | -15.00M | |||
| Stock Issued/Repurchased | 13.85M | 14.47M | -40.00K | 720.00K | 81.72M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | -380.00K | |||
| FINANCING CASH FLOW | 13.22M | 14.47M | 4.96M | 720.00K | 66.35M | |||
| Exchange Rate Effect | -103.99K | -99.77K | -260.00K | -20.00K | 130.00K | |||
| CHANGE IN CASH | -10.64M | -8.22M | -29.99M | -17.59M | 59.19M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -23.37M | -21.66M | -28.23M | -14.01M | -5.61M | |||
| Capital Expenditure | -383.26K | -936.24K | -6.46M | -4.28M | -1.68M | |||
| FREE CASH FLOW | -23.76M | -22.59M | -34.69M | -18.29M | -7.29M | |||
All data in USD